Andrew Spillane
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 4
- Cutaneous Melanoma Detection and Management 2
- Cancer Immunotherapy and Biomarkers 2
-
- Gastrointestinal Tumor Research and Treatment 1
- Journals
- Cancer Cell (1 paper)Cell Reports (1 paper)Immunity (1 paper)New England Journal of Medicine (1 paper)Nature Medicine (1 paper)
- Partner nations
- AustraliaUnited StatesNetherlands
In The Last Decade
Andrew Spillane
5 papers receiving 5.8k citations
Andrew Spillane's Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 2.3k
- Cancer Research 1.2k
- Immunology 1.3k
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 1.7k
Countries citing papers authored by Andrew Spillane
This map shows the geographic impact of Andrew Spillane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Spillane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Spillane more than expected).
Fields of papers citing papers by Andrew Spillane
This network shows the impact of papers produced by Andrew Spillane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Spillane. The network helps show where Andrew Spillane may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The Immune Landscape of Cancer Hit paper breakdown → | 2018 | 4331 |
| 2 | Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images Hit paper breakdown → | 2018 | 761 |
| 3 | Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas Hit paper breakdown → | 2018 | 423 |
| 4 | Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma Hit paper breakdown → | 2024 | 305 |
| 5 | 2026 | 1 |
About Andrew Spillane
Andrew Spillane is a scholar working on Oncology, Gastroenterology, Biophysics, Pulmonary and Respiratory Medicine and Cancer Research, having authored 5 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Ferroptosis and cancer prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper), Gastric Cancer Management and Outcomes (1 paper), Genetic factors in colorectal cancer (1 paper), Gastrointestinal Tumor Research and Treatment (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (1.2k citations), Immunology (1.3k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Molecular Biology (1.7k citations). Andrew Spillane has collaborated with scholars based in Australia, United States and Netherlands. Their work appears in journals such as Cancer Cell, Cell Reports, Immunity, New England Journal of Medicine and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.